Clinical Trial: A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547995) titled 'A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.' on April 14.

Brief Summary: This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.

Study Start Date: June 18

Study Type: INTERVENTIONAL

Condition: Uveitis

Intervention: DRUG: GenSci048 High-dose

High-dose Administered SC.

DRUG: GenSci048 Low-dose

Low-dose Administered SC.

DRUG: Placebo

Administered SC.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Disclaimer: Curated by HT Syndication....